Overview

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .

Status:
NOT_YET_RECRUITING

Trial end date:
2028-01-01

Target enrollment:

Participant gender:

Summary

This is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type AEveotoxin adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with upper limb spasticity.

Phase:

PHASE3

Details

Lead Sponsor:

JHM BioPharma (Tonghua) Co. , Ltd.

Treatments:

Injections